ADMA Biologics, Inc. (ADMA)
8.05
-0.10
(-1.23%)
USD |
NASDAQ |
May 27, 13:07
ADMA Biologics Cash from Investing (Quarterly) : 2.404M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| Inovio Pharmaceuticals, Inc. | 2.636M |
| Palisade Bio, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| AnaptysBio, Inc. | 34.98M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.25M |
| Cash from Financing (Quarterly) | -10.13M |
| Free Cash Flow | 107.55M |
| Free Cash Flow Per Share (Quarterly) | 0.2319 |
| Free Cash Flow to Equity (Quarterly) | -68.87M |
| Free Cash Flow to Firm (Quarterly) | 57.32M |
| Free Cash Flow Yield | 5.47% |